Taysha Gene Therapies Statistics
Total Valuation
TSHA has a market cap or net worth of $568.85 million. The enterprise value is $513.89 million.
Important Dates
The last earnings date was Thursday, May 15, 2025, before market open.
| Earnings Date | May 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSHA has 214.66 million shares outstanding. The number of shares has increased by 64.21% in one year.
| Current Share Class | 214.66M |
| Shares Outstanding | 214.66M |
| Shares Change (YoY) | +64.21% |
| Shares Change (QoQ) | +0.34% |
| Owned by Insiders (%) | 13.08% |
| Owned by Institutions (%) | 57.77% |
| Float | 136.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 95.25 |
| Forward PS | 93.15 |
| PB Ratio | 9.87 |
| P/TBV Ratio | 10.33 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 71.14 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.35, with a Debt / Equity ratio of 1.12.
| Current Ratio | 5.35 |
| Quick Ratio | 5.17 |
| Debt / Equity | 1.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -909.91 |
Financial Efficiency
Return on equity (ROE) is -159.34% and return on invested capital (ROIC) is -45.12%.
| Return on Equity (ROE) | -159.34% |
| Return on Assets (ROA) | -35.91% |
| Return on Invested Capital (ROIC) | -45.12% |
| Return on Capital Employed (ROCE) | -72.29% |
| Revenue Per Employee | $98,959 |
| Profits Per Employee | -$1.19M |
| Employee Count | 73 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.33% in the last 52 weeks. The beta is 1.02, so TSHA's price volatility has been similar to the market average.
| Beta (5Y) | 1.02 |
| 52-Week Price Change | -29.33% |
| 50-Day Moving Average | 2.13 |
| 200-Day Moving Average | 1.97 |
| Relative Strength Index (RSI) | 53.97 |
| Average Volume (20 Days) | 5,315,255 |
Short Selling Information
The latest short interest is 31.98 million, so 14.90% of the outstanding shares have been sold short.
| Short Interest | 31.98M |
| Short Previous Month | 26.24M |
| Short % of Shares Out | 14.90% |
| Short % of Float | 23.36% |
| Short Ratio (days to cover) | 6.29 |
Income Statement
In the last 12 months, TSHA had revenue of $7.22 million and -$86.77 million in losses. Loss per share was -$0.33.
| Revenue | 7.22M |
| Gross Profit | 7.22M |
| Operating Income | -83.71M |
| Pretax Income | -118.01M |
| Net Income | -86.77M |
| EBITDA | -82.51M |
| EBIT | -83.71M |
| Loss Per Share | -$0.33 |
Full Income StatementBalance Sheet
The company has $116.59 million in cash and $61.63 million in debt, giving a net cash position of $54.96 million or $0.26 per share.
| Cash & Cash Equivalents | 116.59M |
| Total Debt | 61.63M |
| Net Cash | 54.96M |
| Net Cash Per Share | $0.26 |
| Equity (Book Value) | 55.06M |
| Book Value Per Share | 0.27 |
| Working Capital | 98.15M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$83.45 million and capital expenditures -$612,000, giving a free cash flow of -$84.06 million.
| Operating Cash Flow | -83.45M |
| Capital Expenditures | -612,000 |
| Free Cash Flow | -84.06M |
| FCF Per Share | -$0.39 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -1,158.80% |
| Pretax Margin | -1,201.08% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSHA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -64.21% |
| Shareholder Yield | -64.21% |
| Earnings Yield | -15.25% |
| FCF Yield | -14.78% |
Analyst Forecast
The average price target for TSHA is $7.57, which is 185.66% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.57 |
| Price Target Difference | 185.66% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 122.75% |
| EPS Growth Forecast (5Y) | -20.66% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TSHA has an Altman Z-Score of -4.23 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.23 |
| Piotroski F-Score | 2 |